Type
. The time interval between the start of anti-leprosy treatment and the development of reactions in borderline patients. Leprosy review [Internet]. 1978;49(2):153-7. Available from: http://leprev.ilsl.br/pdfs/1978/v49n2/pdf/v49n2a08.pdf
Type
. Superficial peroneal nerve thickening as an early diagnostic sign in leprosy. Leprosy review [Internet]. 1978;49(2):149-51. Available from: http://leprev.ilsl.br/pdfs/1978/v49n2/pdf/v49n2a07.pdf
Type
. The dermatological clinic in a leprosy control scheme: 10 years' experience in Malawi. Leprosy review [Internet]. 1978;49(2):141-7. Available from: http://leprev.ilsl.br/pdfs/1978/v49n2/pdf/v49n2a06.pdf
Type
. Proven primary dapsone resistance in leprosy--a case report. Leprosy review [Internet]. 1978;49(2):127-30. Available from: http://leprev.ilsl.br/pdfs/1978/v49n2/pdf/v49n2a04.pdf
Type
. Drugs for combined therapy: experimental studies on the antileprosy activity of ethionamide and prothionamide, and a general review. Leprosy review [Internet]. 1978;49(2):115-26. Available from: http://leprev.ilsl.br/pdfs/1978/v49n2/pdf/v49n2a03.pdf
Type
. [Picture report. Chondrodermatitis nodularis chronica helicis, gout tophi, lymphadenosis benigna cutis, lepra lepromatosa, sarcoidosis, lupus vulgaris, ulcerating specific skin infiltrates in lymphatic leukemia, spinocellular carcinoma]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete. 1978;29(6):345-6.
Type
. Erythema nodosum. A review. Cutis. 1978;21(6):806-10.
Type
. Significance of neutrophil activation in reactional lepromatous leprosy: effects of thalidomide in vivo and in vitro. Activation in adjuvant disease. International archives of allergy and applied immunology. 1978;57(4):317-32.
Type
. Combined therapy in leprosy. Background and findings. Chemotherapy. 1978;24(3):187-201.
Type
. A survey on eye involvement among leprosy patients in The Netherlands. Documenta ophthalmologica. Advances in ophthalmology. 1983;56(1-2):69-76.